Detalles de la búsqueda
1.
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C.
N Engl J Med
; 389(23): 2125-2139, 2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37870968
2.
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 436, 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38589856
3.
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv).
Br J Cancer
; 128(5): 877-885, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36482190
4.
Unexpected finding of a rare pathogenic germline BRCA1 variant in an intrahepatic cholangiocarcinoma using the Oncomine Focus DNA assay: clinical and diagnostic implications.
Mol Biol Rep
; 50(8): 7113-7120, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37340184
5.
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 23(7): 876-887, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35636444
6.
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy.
BMC Cancer
; 22(1): 67, 2022 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35033008
7.
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?
Support Care Cancer
; 30(3): 2455-2465, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34779921
8.
The impact of the histological classification of ampullary carcinomas on long-term outcomes after pancreaticoduodenectomy: a single tertiary referral center evaluation.
Langenbecks Arch Surg
; 407(7): 2811-2821, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35670860
9.
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer.
BMC Cancer
; 20(1): 683, 2020 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32698790
10.
Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification.
Int J Mol Sci
; 21(17)2020 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32887490
11.
CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer.
Br J Cancer
; 121(7): 593-599, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31474758
12.
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 563, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38711003
13.
The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients.
BMC Cancer
; 18(1): 98, 2018 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29370781
14.
Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.
Cancer
; 123(22): 4506-4514, 2017 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28708932
15.
Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer.
Br J Cancer
; 116(3): 318-323, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28081548
16.
Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
N Engl J Med
; 371(17): 1609-18, 2014 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-25337750
17.
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.
BMC Cancer
; 17(1): 408, 2017 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28599628
18.
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer.
Br J Cancer
; 114(1): 30-6, 2016 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26575603
19.
Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer.
Oncologist
; 21(8): 988-94, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27382031
20.
An interview with Alfredo Falcone and Lisa Salvatore: RECOURSE and trifluridine/tipiracil in metastatic colorectal cancer.
Future Oncol
; 12(18): 2065-9, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27266889